Sette will be responsible for driving the polymer extrusion and catheter manufacturing company’s financial strategy and operational performance as the company continues to accelerate growth post-acquisition. He has more than a decade of experience in the medical device industry.
Prior to joining Zeus, Sette was CFO of Spectra Medical Devices. He has also held numerous roles with varying responsibilities at BD.
“We are thrilled to welcome Tim to the Zeus leadership team,” CEO Paddy O’Brien said in a news release. “With his deep industry expertise and proven financial acumen, Tim is exactly the leader we need to strengthen our financial strategy and operational performance. We are confident he will play a pivotal role in helping us realize our ambitious growth plans.”
Sette will also oversee all financial functions, including strategic planning, risk management and investor relations.
“I am excited to join Zeus at such a transformative time in its journey,” Sette said. “The company is well-positioned to capitalize on market opportunities, and I look forward to working closely with the leadership team to execute a financial strategy that supports sustainable growth and delivers long-term value to our customers, investors, and stakeholders.”
